← Leaderboards
Archis Bagati
Pyrojas Inc
$1,747,620
Attributed
$1,747,620
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.3K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,747,620 · 1
By mechanism
R44$1,747,620 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adverse Reactions”
- John Alam · Eip Pharma, Inc.$10,536,018
- Jacob Glanville · Centivax Inc$2,987,953
- Jesse Mischa McFarland · Shasqi, Inc.$2,546,903
- Victoria Shier · University Of Southern California$2,464,399
- Chintan Dave · Rutgers Biomedical And Health Sciences$2,055,703
- Brian Kearney · Exavir Therapeutics Inc.$2,049,975
Research focus
Adverse ReactionsAnimal ModelAntigen TargetingAftercareB-Cell LymphomasBenchmarkingBioluminescenceBioluminescence ImagingBreast Cancer CellAntitumor EffectBurden Of IllnessCancer PatientCar T Cell TherapyCd19 GeneCell KillingCell LineCell ModelCell ProliferationCellsChimeric Antigen ReceptorChimeric Antigen Receptor T CellsChimeric ProteinsClinical DevelopmentClinical Trials